We have chosen anakinra treatment, as IL-1 is proven to be the key regulator of inflammation after COVID vaccination [11] and it was also used to treat inflammatory disease bursts [52] as well as myocarditis cases [53] associated with cytokine storms caused by COVID-19 vaccines. Here, IL1B is linked to myocarditis.